| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Can EGFR mutations in plasma or serum be predictive markers of non-small-cell lung cancer? A meta-analysis
|
Wu, Ying
|
|
2015
|
88 |
3 |
p. 246-253
8 p.
|
artikel
|
| 2 |
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer
|
Sher, David J.
|
|
2015
|
88 |
3 |
p. 267-274
8 p.
|
artikel
|
| 3 |
Contents
|
|
|
2015
|
88 |
3 |
p. v-vi
nvt p.
|
artikel
|
| 4 |
Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales
|
Beckett, P.
|
|
2015
|
88 |
3 |
p. 344-348
5 p.
|
artikel
|
| 5 |
Does myasthenia gravis influence overall survival and cumulative incidence of recurrence in thymoma patients? A Retrospective clinicopathological multicentre analysis on 797 patients
|
Filosso, Pier Luigi
|
|
2015
|
88 |
3 |
p. 338-343
6 p.
|
artikel
|
| 6 |
Editorial Board
|
|
|
2015
|
88 |
3 |
p. iii-
1 p.
|
artikel
|
| 7 |
Identification of a novel TMEM106B-ROS1 fusion variant in lung adenocarcinoma by comprehensive genomic profiling
|
Ou, Sai-Hong Ignatius
|
|
2015
|
88 |
3 |
p. 352-354
3 p.
|
artikel
|
| 8 |
Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma
|
Cornelissen, Robin
|
|
2015
|
88 |
3 |
p. 332-337
6 p.
|
artikel
|
| 9 |
Metronomic vinorelbine (oral) in combination with sorafenib in advanced non-small cell lung cancer
|
Tan, Eng Huat
|
|
2015
|
88 |
3 |
p. 289-296
8 p.
|
artikel
|
| 10 |
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
|
Chang, Yih-Leong
|
|
2015
|
88 |
3 |
p. 254-259
6 p.
|
artikel
|
| 11 |
Phase I study of the HER3-targeted antibody patritumab (U3-1287) combined with erlotinib in Japanese patients with non-small cell lung cancer
|
Nishio, Makoto
|
|
2015
|
88 |
3 |
p. 275-281
7 p.
|
artikel
|
| 12 |
Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients
|
Buti, Sebastiano
|
|
2015
|
88 |
3 |
p. 319-324
6 p.
|
artikel
|
| 13 |
Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors
|
Simmons, Claribel P.
|
|
2015
|
88 |
3 |
p. 304-309
6 p.
|
artikel
|
| 14 |
Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer
|
Osugi, Jun
|
|
2015
|
88 |
3 |
p. 310-318
9 p.
|
artikel
|
| 15 |
Radiation necrosis presenting as pseudoprogression (PsP) during alectinib treatment of previously radiated brain metastases in ALK-positive NSCLC: Implications for disease assessment and management
|
Ou, Sai-Hong Ignatius
|
|
2015
|
88 |
3 |
p. 355-359
5 p.
|
artikel
|
| 16 |
Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients
|
Arrieta, Oscar
|
|
2015
|
88 |
3 |
p. 282-288
7 p.
|
artikel
|
| 17 |
Successful treatment with alectinib after crizotinib-induced esophageal ulceration
|
Yoneshima, Yasuto
|
|
2015
|
88 |
3 |
p. 349-351
3 p.
|
artikel
|
| 18 |
Telomere length variation: A potential new telomere biomarker for lung cancer risk
|
Sun, Bing
|
|
2015
|
88 |
3 |
p. 297-303
7 p.
|
artikel
|
| 19 |
The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer
|
Park, Ji Soo
|
|
2015
|
88 |
3 |
p. 325-331
7 p.
|
artikel
|
| 20 |
Tree-in-bud pattern in central lung cancer: CT findings and pathologic correlation
|
Li, Qi
|
|
2015
|
88 |
3 |
p. 260-266
7 p.
|
artikel
|
| 21 |
USP22 promotes tumor progression and induces epithelial–mesenchymal transition in lung adenocarcinoma
|
Hu, Jing
|
|
2015
|
88 |
3 |
p. 239-245
7 p.
|
artikel
|
Tijdschrift beschrijving